Skip to main content

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance

Drug Safety volume 38, pages 1211–1218 (2015)Cite this article

Abstract

Introduction

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, severe and potentially fatal cutaneous adverse drug reaction (the mortality rate is up to 10 %) associated with numerous and apparently heterogeneous drugs. The aetiology is unknown.

Objective

To report Italian cases of DRESS over a 10-year period.

Methods

We searched the National Pharmacovigilance Network (NPN) for the term ‘drug reaction with eosinophilia and systemic symptoms’ from 1 January 2004 to 1 January 2014, to identify all reports of DRESS. Each case was checked to avoid duplication.

Results

In the NPN, we identified 91 serious cases of DRESS: 68 were spontaneous, still-unpublished reports, while 23 additional cases were derived from screening of the scientific literature, performed by marketing authorization holders. Notably, the single common element linking all cases of DRESS was intake of a drug containing an aromatic ring.

Conclusion

Thanks to the largest national DRESS case series ever reported, we were able to hypothesize, for the first time, that there is an association between use of drugs containing an aromatic ring in their chemical structure and DRESS. This might aid understanding of the aetiology of DRESS and facilitate diagnosis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Kauppinen K, Alanko K, Hannuksela M, Maibach HI. Skin reactions to drugs. 1st ed. Boca Raton: CRC; 1998.

    Google Scholar 

  2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rush with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250–7.

    CAS  Article  PubMed  Google Scholar 

  3. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–11.

    CAS  Article  PubMed  Google Scholar 

  4. Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipilectic drugs. Eur J Clin Pharmacol. 2011;67:463–70.

    CAS  Article  PubMed  Google Scholar 

  5. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–80.

    CAS  Article  PubMed  Google Scholar 

  6. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588–97.

    CAS  Article  PubMed  Google Scholar 

  7. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986;105:179–84.

    CAS  Article  PubMed  Google Scholar 

  8. Illing PT, Vivian JP, Dudek NL, et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 2012;486:554–8.

    CAS  PubMed  Google Scholar 

  9. Camous X, Calbo S, Picard D, Musette P. Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol. 2012;24:730–5.

    CAS  Article  PubMed  Google Scholar 

  10. Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010;2:46ra62.

  11. Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singap Med J. 2010;51:767–74.

    CAS  Google Scholar 

  12. Sultan SJ, Sameem F, Ashraf M. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients. Int J Dermatol. 2015;54:537–42.

    CAS  Article  PubMed  Google Scholar 

  13. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013;68(693):e1–14.

    Google Scholar 

  14. Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol. 2015;29:801–4.

    CAS  Article  PubMed  Google Scholar 

  15. Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol. 2013;68:459–65.

    Article  PubMed  Google Scholar 

  16. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. Management and therapeutics. J Am Acad Dermatol. 2013;68:709.

    Article  PubMed  Google Scholar 

  17. Choon SE, Lai NM. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Indian J Dermatol Venereol Leprol. 2012;78:734–9.

    Article  PubMed  Google Scholar 

  18. Grando LR, Schmitt TA, Bakos RM. Severe cutaneous reactions to drugs in the setting of a general hospital. An Bras Dermatol. 2014;89:758–62.

    PubMed Central  Article  PubMed  Google Scholar 

  19. Mokhtari F, Nikyar Z, Naeini BA, Esfahani AA, Rahmani S. Adverse cutaneous drug reactions: eight year assessment in hospitalized patients. J Res Med Sci. 2014;19:720–5.

    PubMed Central  PubMed  Google Scholar 

  20. Chaabane A, Aouam K, Ben Fredj N, Boughattas NA. DRESS syndrome: 11 case reports and a literature review. Therapie. 2010;65:543–50.

    Article  PubMed  Google Scholar 

  21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    CAS  Article  PubMed  Google Scholar 

  22. Kano Y, Tohyama Aihara M, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol. 2015;42:276–82.

    Article  PubMed  Google Scholar 

  23. Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87:435–49.

    Article  PubMed  Google Scholar 

  24. Hernández N, Borrego L, Soler E, Hernández J. Sulfasalazine-induced linear immunoglobulin A bullous dermatosis with DRESS. Actas Dermosifiliogr. 2013;104:343–6.

    Article  PubMed  Google Scholar 

  25. Das KM, Eastwood MA, McManus JP, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylatorphenotype. N Engl J Med. 1973;289:491–5.

    CAS  Article  PubMed  Google Scholar 

  26. Moling O, Tappeiner L, Piccin A, et al. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir—a hypothesis. Med Sci Monit. 2012;18:CS57–62.

  27. Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin Immunol. 2011;10(7 Suppl 1):S10.

    Article  Google Scholar 

  28. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;76:47–56.

    CAS  Article  PubMed  Google Scholar 

  29. Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-De la Villa F. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ. 2005;331:623–4.

    PubMed Central  Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Roberta Maj and Federico Masserini for their support in revising the manuscript.

Author information

Affiliations

  1. Italian Medicines Agency, Rome, Italy

    Francesca Renda, Renato Bertini Malgarini, Alessandro Assisi, Giuseppe Pimpinella & Luca Pani

  2. IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy

    Giovanni Landoni, Maria Luisa Azzolini & Marta Mucchetti

  3. Vita-Salute San Raffaele University, Milan, Italy

    Giovanni Landoni

Authors
  1. Francesca Renda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Landoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato Bertini Malgarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Assisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Luisa Azzolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marta Mucchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giuseppe Pimpinella
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luca Pani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Landoni.

Ethics declarations

Funding

This work was supported by departmental funds only. The departments had no role in the design of the study; analysis and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.

Conflict of interest

Francesca Renda, Giovanni Landoni, Renato Bertini Malgarini, Alessandro Assisi, Maria Luisa Azzolini, Marta Mucchetti, Giuseppe Pimpinella and Luca Pani have no conflicts of interest that are directly relevant to the content of this study.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Renda, F., Landoni, G., Bertini Malgarini, R. et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance. Drug Saf 38, 1211–1218 (2015). https://doi.org/10.1007/s40264-015-0343-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-015-0343-3

Keywords

  • Adverse Drug Reaction
  • Lamotrigine
  • Allopurinol
  • Strontium Ranelate
  • Suspected Drug